Shan Binbin, Zhang Quanmao, Li Yuan, Han Fucai
Pneumology Department Endoscopy Center, Shanxi Provincial Cancer Hospital, Taiyuan, Shanxi, China.
Medicine (Baltimore). 2017 Nov;96(45):e8623. doi: 10.1097/MD.0000000000008623.
In clinical work, neuroendocrine synchronous multiplicity carcinoma was relatively rare. Most were confirmed by the pathological diagnosis of a certain part of the body combined with the imaging of the whole body, while cases that had both pathological and immunohistochemistry diagnosis were few.
A patient who presented with abdominal pain visited our hospital, and was diagnosed with lesions in both the small intestine and lung.
Both were considered primary tumors by imaging, and diagnosed as neuroendocrine carcinomas by pathology.
The intestinal lesion was surgically resected, and the lung tumor treated by chemoradiotherapy.
The survival time of this patient exceeded 24 months.
The diagnosis relied on clinical, imaging, pathological, and immunohistochemical features, which confirmed a synchronous multiple carcinoma. Treatment was based on the pathological types. Through this case report, the clinical and pathological data of neuroendocrine synchronous multiplicity carcinoma could be enriched.
在临床工作中,神经内分泌同步多发癌相对少见。多数通过身体某一部位的病理诊断结合全身影像学检查得以确诊,而同时具备病理及免疫组化诊断的病例较少。
一名因腹痛前来我院就诊的患者,被诊断为小肠和肺部均有病变。
影像学检查均考虑为原发性肿瘤,病理诊断为神经内分泌癌。
对肠道病变进行手术切除,肺部肿瘤采用放化疗治疗。
该患者生存时间超过24个月。
诊断依赖于临床、影像学、病理及免疫组化特征,确诊为同步多发癌。治疗基于病理类型。通过本病例报告,可丰富神经内分泌同步多发癌的临床及病理资料。